Page last updated: 2024-10-22

antipyrine and Cardiometabolic Syndrome

antipyrine has been researched along with Cardiometabolic Syndrome in 1 studies

Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.

Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaneko, K1
Yonemitsu, Y1
Fujii, T1
Onimaru, M1
Jin, CH1
Inoue, M1
Hasegawa, M1
Onohara, T1
Maehara, Y1
Sueishi, K1

Other Studies

1 other study available for antipyrine and Cardiometabolic Syndrome

ArticleYear
A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:4

    Topics: Angiogenesis Inducing Agents; Animals; Antipyrine; Edaravone; Fibroblast Growth Factor 2; Free Radic

2006